1/15
04:05 pm
bctx
BriaCell Therapeutics Announces Closing of US$30 million Public Offering
Medium
Report
BriaCell Therapeutics Announces Closing of US$30 million Public Offering
1/14
01:38 am
bctx
BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit [Seeking Alpha]
High
Report
BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit [Seeking Alpha]
1/13
09:00 pm
bctx
BriaCell Therapeutics Announces Pricing of $30 million Public Offering
High
Report
BriaCell Therapeutics Announces Pricing of $30 million Public Offering
1/7
10:32 am
bctx
How $594B in Precision Tech is Cracking the Metastatic Cancer Code
Low
Report
How $594B in Precision Tech is Cracking the Metastatic Cancer Code
12/18
07:42 am
bctx
“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine [Yahoo! Finance]
Low
Report
“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine [Yahoo! Finance]
12/18
07:30 am
bctx
“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine
Low
Report
“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine
12/10
07:30 am
bctx
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
High
Report
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
12/9
07:30 am
bctx
BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout
Medium
Report
BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout
12/2
07:30 am
bctx
BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025
Medium
Report
BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025
11/25
07:30 am
bctx
BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025
High
Report
BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025
11/20
07:30 am
bctx
BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics
Medium
Report
BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics
11/18
07:30 am
bctx
BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025
Medium
Report
BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025
11/7
09:28 am
bctx
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025 [Canadian Business Journal (Canada)]
High
Report
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025 [Canadian Business Journal (Canada)]
11/7
07:30 am
bctx
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025
High
Report
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025
11/4
07:30 am
bctx
BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models
Medium
Report
BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models
10/22
07:30 am
bctx
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
Medium
Report
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
10/21
07:50 am
bctx
BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study
Low
Report
BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study
10/21
07:30 am
bctx
BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer
Low
Report
BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer